Device type · PZR
Percutaneous Nerve Stimulator For Opioid Withdrawal
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
PZR
Neurology
Device class
Class II
FDA decisions since 2015
8
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Percutaneous Nerve Stimulator For Opioid Withdrawal
- Product code
- PZR
- Device class
- Class II
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5896
- Specialty
- Neurology & Neurosurgery, Neuromodulation
- FDA record
- Classification database entry for PZR
Latest FDA decisions
- Sparrow Ascent510(k)
K251246 · Decided Aug 25, 2025 · 125 days after receipt
Device type: Percutaneous Nerve Stimulator For Opioid Withdrawal (PZR) · Neurology & Neurosurgery
K233166 · Decided May 29, 2024 · 245 days after receipt
Device type: Percutaneous Nerve Stimulator For Opioid Withdrawal (PZR) · Neurology & Neurosurgery
- Sparrow Ascent510(k)
K230796 · Decided Jun 20, 2023 · 90 days after receipt
Device type: Percutaneous Nerve Stimulator For Opioid Withdrawal (PZR) · Neurology & Neurosurgery
5 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Sparrow Ascent Patient Controller, REF's: 11-110-K, 11-310-K, 11-320-K, 11-321-K, 11-310-K-28, 11-320-K-28, 11-321-K-28Open, Classified
Z-2287-2025 · Started Jul 2, 2025 · Posted by FDA Aug 11, 2025
Reason given: Due to manufacturing issue, neurostimulator device may experience "cable disconnect" error message and interruption to stimulation output.
Cause as FDA categorized it: Process control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.